AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AGRX

<< 이전 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2018/06/22	05:33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/06/09	06:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/06/09	06:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/06/09	06:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/06/09	06:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/06/09	06:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/06/09	06:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/06/08	05:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/06/08	05:10	GlobeNewswire Inc.	Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance	NASDAQ:AGRX	Agile Therapeutics Inc
2018/05/23	00:53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/05/19	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/05/18	20:30	GlobeNewswire Inc.	Agile Therapeutics, Inc. Provides Regulatory Update on Twirla® (AG200-15) for the Prevention of Pregnancy	NASDAQ:AGRX	Agile Therapeutics Inc
2018/05/11	01:24	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/05/08	05:29	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/05/08	05:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/05/08	05:10	GlobeNewswire Inc.	Agile Therapeutics Reports First Quarter 2018 Financial Results	NASDAQ:AGRX	Agile Therapeutics Inc
2018/05/04	21:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/04/28	05:43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/04/26	05:33	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/03/29	05:28	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/03/29	05:15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/03/14	20:45	GlobeNewswire Inc.	Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition	NASDAQ:AGRX	Agile Therapeutics Inc
2018/03/13	05:29	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/03/13	05:21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/03/13	05:15	GlobeNewswire Inc.	Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results	NASDAQ:AGRX	Agile Therapeutics Inc
2018/02/14	23:33	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/02/14	07:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/02/10	06:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/02/06	06:37	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AGRX	Agile Therapeutics Inc
2018/02/02	06:36	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:AGRX	Agile Therapeutics Inc